About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETED

Phenotyping of Small Bowel Adenocarcinoma

NCT02976090•Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Small Bowel Adenocarcinoma

Key Dates

Start Date

January 1, 2017

Primary Completion Date

December 15, 2019

Completion Date

December 24, 2020

Last Updated

January 13, 2021

Related Studies

RECRUITINGPhase 2

Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy

NCT07347314

Advanced Small Bowel Adenocarcinoma

Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma

NCT02502370

Small Bowel AdenocarcinomaAdjuvant Chemotherapy for SBA

Sponsors

Lead Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

University of Paris 5 - Rene Descartes
Centre Hospitalier Universitaire de Besancon
GERCOR - Multidisciplinary Oncology Cooperative Group

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions